Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3298869
Max Phase: Preclinical
Molecular Formula: C17H21NO5
Molecular Weight: 203.28
Molecule Type: Small molecule
Associated Items:
ID: ALA3298869
Max Phase: Preclinical
Molecular Formula: C17H21NO5
Molecular Weight: 203.28
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(C(=O)C(C)NC2CC2)cc1.O=C(O)/C=C/C(=O)O
Standard InChI: InChI=1S/C13H17NO.C4H4O4/c1-9-3-5-11(6-4-9)13(15)10(2)14-12-7-8-12;5-3(6)1-2-4(7)8/h3-6,10,12,14H,7-8H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1+
Standard InChI Key: YMEOVQVIOMPXPW-WLHGVMLRSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 203.28 | Molecular Weight (Monoisotopic): 203.1310 | AlogP: 2.32 | #Rotatable Bonds: 4 |
Polar Surface Area: 29.10 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.81 | CX LogP: 2.59 | CX LogD: 2.04 |
Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.76 | Np Likeness Score: -0.67 |
1. Blough BE, Landavazo A, Partilla JS, Baumann MH, Decker AM, Page KM, Rothman RB.. (2014) Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics., 5 (6): [PMID:24944732] [10.1021/ml500113s] |
Source(1):